911 related articles for article (PubMed ID: 20056917)
1. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
[TBL] [Abstract][Full Text] [Related]
2. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
[TBL] [Abstract][Full Text] [Related]
3. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
4. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
[TBL] [Abstract][Full Text] [Related]
5. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
[TBL] [Abstract][Full Text] [Related]
6. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
[TBL] [Abstract][Full Text] [Related]
7. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
[TBL] [Abstract][Full Text] [Related]
8. Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction.
Kandalam V; Basu R; Abraham T; Wang X; Awad A; Wang W; Lopaschuk GD; Maeda N; Oudit GY; Kassiri Z
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1012-23. PubMed ID: 20675565
[TBL] [Abstract][Full Text] [Related]
9. Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-myocardial infarction remodeling in mice.
Zavadzkas JA; Stroud RE; Bouges S; Mukherjee R; Jones JR; Patel RK; McDermott PJ; Spinale FG
Circ Res; 2014 Apr; 114(9):1435-45. PubMed ID: 24637197
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in MT1-MMP activity with ischemia-reperfusion and previous myocardial infarction: relation to regional myocardial function.
Dixon JA; Gaillard WF; Rivers WT; Koval CN; Stroud RE; Mukherjee R; Spinale FG
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1947-58. PubMed ID: 20935147
[TBL] [Abstract][Full Text] [Related]
11. Myocardial recovery from ischemia-reperfusion is compromised in the absence of tissue inhibitor of metalloproteinase 4.
Takawale A; Fan D; Basu R; Shen M; Parajuli N; Wang W; Wang X; Oudit GY; Kassiri Z
Circ Heart Fail; 2014 Jul; 7(4):652-62. PubMed ID: 24842912
[TBL] [Abstract][Full Text] [Related]
12. Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution.
Iyer RP; Patterson NL; Zouein FA; Ma Y; Dive V; de Castro Brás LE; Lindsey ML
Int J Cardiol; 2015 Apr; 185():198-208. PubMed ID: 25797678
[TBL] [Abstract][Full Text] [Related]
13. Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction.
Spinale FG; Mukherjee R; Zavadzkas JA; Koval CN; Bouges S; Stroud RE; Dobrucki LW; Sinusas AJ
J Biol Chem; 2010 Sep; 285(39):30316-27. PubMed ID: 20643648
[TBL] [Abstract][Full Text] [Related]
14. Age-related differences in postinfarct left ventricular rupture and remodeling.
Yang Y; Ma Y; Han W; Li J; Xiang Y; Liu F; Ma X; Zhang J; Fu Z; Su YD; Du XJ; Gao XM
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1815-22. PubMed ID: 18263717
[TBL] [Abstract][Full Text] [Related]
15. Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.
Zheng XX; Li XY; Lyu YN; He YY; Wan WG; Zhu HL; Jiang XJ
Exp Physiol; 2016 Feb; 101(2):260-71. PubMed ID: 26556551
[TBL] [Abstract][Full Text] [Related]
16. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
Iyer RP; de Castro Brás LE; Patterson NL; Bhowmick M; Flynn ER; Asher M; Cannon PL; Deleon-Pennell KY; Fields GB; Lindsey ML
J Mol Cell Cardiol; 2016 Nov; 100():109-117. PubMed ID: 27746126
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
Krishnamurthy P; Peterson JT; Subramanian V; Singh M; Singh K
Mol Cell Biochem; 2009 Feb; 322(1-2):53-62. PubMed ID: 18979185
[TBL] [Abstract][Full Text] [Related]
18. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z
Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173
[TBL] [Abstract][Full Text] [Related]
19. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
20. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]